Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma

Plastic and Reconstructive Surgery

Volumn 112, Issue 2, 2003, Pages 486-497

  Wagner, Jeffrey D ^a   Ranieri, Jaimie ^a   Evdokimow, David Z ^a   Logan, Theodore ^a   Chuang, Tsu Yi ^a   Johnson, Cynthia S ^a   Jung, Sin Ho ^a   Wenck, Stacie ^a   Coleman III, John J ^a  

^a RT 471 Cancer Pavilion Bldg ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRESLOW TUMOR THICKNESS; CANCER CYTODIAGNOSIS; CANCER LOCALIZATION; CANCER RECURRENCE; CAUSE OF DEATH; CHILD; CORRELATION ANALYSIS; DEMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; RANK SUM TEST; RELAPSE; SENTINEL LYMPH NODE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT FAILURE; TUMOR BIOPSY; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 0043132307     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000070989.23469.1F     Document Type: Article

References (33)

1. Breslow, A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann. Surg. 172: 1902, 1970.
2. Balch, C. M., Murad, T. M., Soong, S. J., Murad, T. M., Ingalis, A. L., and Maddox, W. A. A multifactorial analysis of melanoma II: Prognostic factors in patients with stage I (localized) melanoma. Surgery 86: 343, 1979.
3. Balch, C. M., Murad, T. M., Soong, S. J., Ingalis, A. L., Richards, P. C., and Maddox, W. A. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer 43: 883, 1979.
4. Soong, S. J., and Weiss, H. L. Predicting outcome in patients with localized melanoma. In C. M. Balch, A. N. Houghton, A. J. Sober, and S. J. Soong (Eds.), Cutaneous Melanoma, 3rd Ed. St. Louis, Mo.: Quality Medical Publishing, 1998. Pp. 51-61.
5. Stadelmann, W. K., Rapaport, D. P., Soong, S. J., Reintgen, D. S., Buzaid, A. C., and Balch, C. M. Prognostic clinical and pathologic features. In C. M. Balch, A. N. Houghton, A. J. Sober, and S. J. Soong (Eds.), Cutaneous Melanoma, 3rd Ed. St. Louis, Mo.: Quality Medical Publishing, 1998. Pp. 11-35.
6. Morton, D. L., Wen, D. R., Wong, J. H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 127: 392, 1992.
7. Reintgen, D., Cruse, C. W., Wells, K., et al. The orderly progression of melanoma nodal metastases. Ann. Surg. 220: 759, 1994.
8. Morton, D. L., Wen, D. R., Foshag, L. J., Essner, R., and Cochran, A. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early stage melanomas of the head and neck. J. Clin. Oncol. 11: 1751, 1993.
9. Albertini, J. J., Cruse, C. W., Rapaport, D., et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann. Surg. 223: 217, 1996.
10. Krag, D. L., Meijer, S. J., Weaver, D. L., et al. Minimal-access surgery for staging of malignant melanoma. Arch. Surg. 130: 654, 1995.
11. Gershenwald, J. E., Thompson, W., Mansfield, P. F., et al. Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J. Clin. Oncol. 17: 976, 1999.
12. MacKie, R. M., Byrne, D., Lyngam, M. K., Sajid, M., and MacKay, A. K. Prognostic evaluation of sentinel node biopsy (Abstract. Melanoma Res. 7: S102, 1997.
13. Wagner, J. D., Gordon, M. S., Chuang, T. Y., et al. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer 89: 453, 2000.
14. McMasters, K. M., Reintgen, D. S., Ross, M. I., et al. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann. Surg. Oncol. 8: 192, 2001.
15. Wagner, J. D., Davidson, D., Coleman J. J., III, et al. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Ann. Surg. Oncol. 6: 398, 1999.
16. Balch, C. M., Buzaid, A. C., Soong, S. J., et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J. Clin. Oncol. 19: 3635, 2001.
17. Balch, C. M., Soong, S. J., Bartolucci, A. A., et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann. Surg. 224: 255, 1996.
18. Cascinelli, N., Morabito, A., Santinami, M., MacKie, R. M., and Belli, F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial. WHO melanoma programme. Lancet 351: 793, 1998.
19. Cascinelli, N., Belli, F., Santinami, M., et al. Sentinel lymph node biopsy in cutaneous melanoma: The WHO melanoma program experience. Ann. Surg. Oncol. 7: 469, 2000.
20. McMasters, K. M., Wong, S. L., Edwards, M. D., et al. Frequency of nonsentinel lymph node metastases in melanoma. Ann. Surg. Oncol. 9: 137, 2002.
21. Haddad, F. F., Stall, A., Messina, J., et al. The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion. Ann. Surg. Oncol. 6: 142, 1999.
22. Gershenwald, J. E., Colome, M. I., Lee, J. E., et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J. Clin. Oncol. 16: 2253, 1998.
23. Essner, R., Rose, D. M., Kojima, M., Huynh, Y., Turner, R., and Morton, D. L. Natural history of melanoma after tumor-negative sentinel lymph node dissection (Abstract). Melanoma Res. 11: S72, 2001.
24. Statius-Muller, M. G., Borgstein, P. J., Pijpers, R., et al. Reliability of the sentinel node procedure in melanoma patients: Analysis of failures after long-term follow-up. Ann. Surg. Oncol. 7: 461, 2000.
25. Kelemen, P. R., Essner, R., Foshag, L. J., and Morton, D. L. Lymphatic mapping and sentinel lymphadenectomy after wide local excision of primary melanoma. J. Am. Coll. Surg. 189: 247, 1999.
26. Landi, G., Polverelli, M., Morelli, R., et al. Lymphatic mapping and sentinel node biopsy after wide excision of cutaneous melanoma (Abstract). Melanoma Res. 11: S106, 2001.
27. Yu, L. L., Flotte, T. J., Tanabe, K. K., et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 86: 617, 1999.
28. Gibbs, J. F., Huang, P. P., Zhang, P. J., Kraybill, W. G., and Cheney, R. Accuracy of pathologic techniques for the diagnosis of metastatic melanoma in sentinel lymph nodes. Ann. Surg. Oncol. 6: 699, 1999.
29. Shivers, S. C., Xiangning, W., Li, W., et al. Molecular staging of malignant melanoma: Correlation with clinical outcome. J.A.M.A. 280: 1410, 1998.
30. Bostick, P. J., Morton, D. L., Turner, R. R., et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early stage melanoma patients. J. Clin. Oncol. 17: 3238, 1999.
31. Kirkwood, J. M., Strawderman, M. H., Ernstaff, M. S., Smith, T. J., Bordern, E. C., and Blum, R. H. Interferon alfa-2b adjuvant therapy of high risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial EST 1684. J. Clin. Oncol. 14: 7, 1996.
32. Balch, C. M., and Buzaid, A. C. Finally, a successful adjuvant therapy for high risk melanoma. J. Clin. Oncol. 14: 1, 1996.
33. Wagner, J. D., Gordon, M. S., Chuang, T. Y., and Coleman, J. J., III. Current therapy of cutaneous melanoma. Plast. Reconstr. Surg. 105: 1774, 2000.